CIB Stock Analysis: Grupo Cibest S.A. | NYSE

Banks - Regional | NYSE, USA | Market Cap: 20.471m USD | 12M Return: 41.6% | US40090E1064 | Charts, Fundamentals & Technical Analysis

Deposit Accounts, Commercial Lending, Capital Markets, Insurance Brokerage
Total Rating 56
Safety 57
Buy Signal -0.13
Diversified Banks
Sub-Industry Rotation: +2.1
Market Cap: 20.5B
Avg Turnover: 25.7M
Risk 3d forecast
Volatility33.0%
VaR 5th Pctl5.59%
VaR vs Median2.74%
Reward TTM
Sharpe Ratio1.07
Rel. Str. IBD79.6
Rel. Str. Peer Group77.3 pctl
Character TTM
Beta0.410
Beta Downside0.138
Hurst Exponent0.603
Choppyness66.8%
Drawdowns 3y
Max DD23.95%
CAGR/Max DD2.72
CAGR/Mean DD12.14
EPS (Earnings per Share) EPS (Earnings per Share) of CIB over the last years for every Quarter: "2021-09": 1.03, "2021-12": 1.51, "2022-03": 1.92, "2022-06": 1.78, "2022-09": 1.48, "2022-12": 1.42, "2023-03": 1.58, "2023-06": 1.45, "2023-09": 1.53, "2023-12": 1.58, "2024-03": 1.8, "2024-06": 1.44, "2024-09": 1.52, "2024-12": 1.57, "2025-03": 1.74, "2025-06": 1.79, "2025-09": 2.18, "2025-12": 1.77, "2026-03": 1.68, "2026-06": 3.32, "2026-09": 2.66,
EPS CAGR: 15.31%
EPS Trend: 88.9%
Last SUE: -0.48
Qual. Beats: 0
Revenue Revenue of CIB over the last years for every Quarter: 2021-09: 5438956, 2021-12: 4809112, 2022-03: 6518824, 2022-06: 7338656, 2022-09: 8703935, 2022-12: 6872933, 2023-03: 11395187, 2023-06: 11250881, 2023-09: 11007575, 2023-12: 11505075, 2024-03: 10769672, 2024-06: 10765718, 2024-09: 10690703, 2024-12: 11007635, 2025-03: 10286636, 2025-06: 10529446, 2025-09: 10657803, 2025-12: 11689172.573, 2026-03: 10463107, 2026-06: 11498822.471, 2026-09: 11693815.864,
Rev. CAGR: -0.33%
Rev. Trend: -13.5%
Last SUE: 0.71
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan +9.6% 21
Feb -2.5% 14
Mar +4.2% 28
Apr -2.5% 14
May -1.7% 14
Jun +3.6% 14
Jul -1.7% 14
Aug +0.2% 0
Sep -2.6% 47
Oct +0.1% 0
Nov +0.6% 9
Dec +1.6% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: CIB Grupo Cibest S.A.

Grupo Cibest S.A. (formerly Bancolombia S.A., renamed in May 2025) is one of Colombias largest diversified banking groups, founded in 1875 and headquartered in Medellín. The company operates as a full-service financial institution offering deposit products, credit solutions including mortgages and credit cards, capital markets services, investment banking, insurance, and trust and fiduciary services across Colombia and international markets.

As a diversified bank in the Financials sector, Grupo Cibest serves retail and corporate clients through an extensive multi-channel distribution network that includes physical branches, mobile branches, ATMs, digital banking, and banking correspondents. The group also operates Nequi, a digital banking platform, alongside specialized services such as cash management, trade finance, and asset management.

Headlines to Watch Out For
  • Net interest margin expands as Colombia holds benchmark rate elevated
  • Loan growth accelerates on strong consumer and corporate credit demand
  • Nequi digital platform scales amid rising fintech competition
Piotroski VR-10 (Strict) 5.5
Net Income: 7601b TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.81 > 1.0
NWC/Revenue: -576.0% < 20% (prev -533.3%; Δ -42.73% < -1%)
CFO/TA 0.04 > 3% & CFO 13448b > Net Income 7601b
Net Debt (2287b) to EBITDA (11384b): 0.20 < 3
Current Ratio: 0.08 > 1.5 & < 3
Outstanding Shares: last quarter (236.2m) vs 12m ago -1.78% < -2%
Gross Margin: 61.00% > 18% (prev 58.59%; Δ 2.41% > 0.5%)
Asset Turnover: 12.19% > 50% (prev 11.34%; Δ 0.85% > 0%)
Interest Coverage Ratio: 0.81 > 6 (EBIT TTM 10359b / Interest Expense TTM 12851b)
Altman Z'' -4.22
A: -0.71 (Total Current Assets 24191b - Total Current Liabilities 285398b) / Total Assets 369162b
B: 0.03 (Retained Earnings 12438b / Total Assets 369162b)
C: 0.03 (EBIT TTM 10359b / Avg Total Assets 371897b)
D: 0.12 (Book Value of Equity 38783b / Total Liabilities 329108b)
Altman-Z'' = -4.22 = D
What is the price of CIB shares?

As of November 21, 2026, the stock is trading at USD 81.55 with a total of 302,555 shares traded. Over the past week, the price has changed by -8.89%, over one month by -14.94%, over three months by -14.63% and over the past year by +41.60%.

Current recommended Stop Loss: 75.70 (which is 7.2% or 1.9 ATR below the current price).

Is CIB a buy, sell or hold?

Grupo Cibest S.A. has received a consensus analysts rating of 3.27. Therefore, it is recommended to hold CIB.

  • StrongBuy: 2
  • Buy: 1
  • Hold: 7
  • Sell: 0
  • StrongSell: 1

What are the forecasts/targets for the CIB price?
Analysts Target Price 90.5 11%
Grupo Cibest S.A. (CIB) - Fundamental Data Overview as of 20 November 2026
Market Cap USD = 20.5b (20.5b USD * 1.0 USD.USD)
Market Cap COP = 68516b (20.5b USD * 3346.9899902344 USD.COP)
P/E Trailing = 5.798
P/E Forward = 7.215
P/S = 2.2706
P/B = 1.7795
P/EG = 0.4343
Revenue TTM = 45345b COP
EBIT TTM = 10359b COP
EBITDA TTM = 11384b COP
Long Term Debt = 15666b COP (from longTermDebt, last quarter)
Short Term Debt = 7187b COP (from shortTermDebt, last quarter)
Debt = 25541b COP (from shortLongTermDebtTotal, last quarter) + Leases 1344b
Net Debt = 2287b COP (calculated: Debt 25541b - CCE 23255b)
Enterprise Value = 70802b COP (68516b + Debt 25541b - CCE 23255b)
Interest Coverage Ratio = 0.81 (Ebit TTM 10359b / Interest Expense TTM 12851b)
EV/FCF = 6.39x (Enterprise Value 70802b / FCF TTM 11088b)
FCF Yield = 15.66% (FCF TTM 11088b / Enterprise Value 70802b)
FCF Margin = 24.45% (FCF TTM 11088b / Revenue TTM 45345b)
Net Margin = 16.76% (Net Income TTM 7601b / Revenue TTM 45345b)
Gross Margin = 61.00% ((Revenue TTM 45345b - Cost of Revenue TTM 17683b) / Revenue TTM)
Gross Margin QoQ = 60.84% (prev 64.60%)
Tobins Q-Ratio = 0.19 (Enterprise Value 70802b / Total Assets 369162b)
 Interest Expense / Debt = 50.31% (Interest Expense 12851b / Debt 25541b)
 Taxrate = 30.67% (3177b / 10359b)
NOPAT = 7182b (EBIT 10359b * (1 - 30.67%))
Current Ratio = 0.08 (Total Current Assets 24191b / Total Current Liabilities 285398b)
Debt / Equity = 0.66 (Debt 25541b / totalStockholderEquity, last quarter 38783b)
Debt / EBITDA = 0.20 (Net Debt 2287b / EBITDA 11384b)
Debt / FCF = 0.21 (Net Debt 2287b / FCF TTM 11088b)
Total Stockholder Equity = 37937b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.04% (Net Income 7601b / Total Assets 369162b)
RoE = 20.04% (Net Income TTM 7601b / Total Stockholder Equity 37937b)
RoCE = 19.33% (EBIT 10359b / Capital Employed (Equity 37937b + L.T.Debt 15666b))
RoIC = 8.10% (NOPAT 7182b / Invested Capital 88684b)
WACC = 5.11% (E(68516b)/V(94057b) * Re(7.02%) + (debt cost/tax rate unavailable))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -84.91 | Cagr: -0.80%
[DCF] Terminal Value 73.10% ; FCFF base≈12369b ; Y1≈10847b ; Y5≈8764b
[DCF] Fair Price = 1.27m (EV 140666b - Net Debt 2287b = Equity 138379b / Shares 109.0m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
 [DCF] Fair Price = 1.27m (out of range, set to none)
 EPS Correlation: 88.89 | EPS CAGR: 15.31% | SUE: -0.48 | # QB: 0
Revenue Correlation: -13.46 | Revenue CAGR: -0.33% | SUE: 0.71 | # QB: 0
EPS current Quarter (2027-03-31): EPS=3.05 | Chg30d=-4.78% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=10.31 | Chg30d=-3.43% | Revisions=-25% | GrowthEPS=+28.0% | GrowthRev=+4.7%
EPS next Year (2027-12-31): EPS=11.61 | Chg30d=+0.25% | Revisions=-25% | GrowthEPS=+12.6% | GrowthRev=+10.2%
[Analyst] Revisions Ratio: -50% (up=0, down=3)